메뉴 건너뛰기




Volumn 51, Issue 5, 2009, Pages 404-407

Guanidinoacetate methyltransferase (GAMT) deficiency: Late onset of movement disorder and preserved expressive language

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CREATINE; GUANIDINOACETATE METHYLTRANSFERASE; GUANIDINOACETIC ACID; ORNITHINE; RISPERIDONE; VALPROIC ACID; VIGABATRIN;

EID: 64849083340     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2008.03227.x     Document Type: Article
Times cited : (21)

References (15)
  • 1
    • 0037306564 scopus 로고    scopus 로고
    • Creatine deficiency syndromes
    • Schulze A. Creatine deficiency syndromes. Mol Cell Biochem 2003; 244: 143-50.
    • (2003) Mol Cell Biochem , vol.244 , pp. 143-150
    • Schulze, A.1
  • 2
    • 0027994133 scopus 로고
    • Creatine deficiency in the brain: A new, treatable inborn error of metabolism
    • Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pediatr Res 1994; 36: 409-413.
    • (1994) Pediatr Res , vol.36 , pp. 409-413
    • Stöckler, S.1    Holzbach, U.2    Hanefeld, F.3
  • 4
    • 33747075772 scopus 로고    scopus 로고
    • GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis
    • Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, et al. GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 2006; 67: 480-84.
    • (2006) Neurology , vol.67 , pp. 480-484
    • Mercimek-Mahmutoglu, S.1    Stoeckler-Ipsiroglu, S.2    Adami, A.3
  • 5
    • 0034032637 scopus 로고    scopus 로고
    • Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect
    • van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P, et al. Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol 2000; 47: 540-43.
    • (2000) Ann Neurol , vol.47 , pp. 540-543
    • van der Knaap, M.S.1    Verhoeven, N.M.2    Maaswinkel-Mooij, P.3
  • 6
    • 34447120039 scopus 로고    scopus 로고
    • Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency
    • Vodopiutz J, Item CB, Häusler M, Korall H, Bodamer OA. Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency. J Child Neurol 2007; 22: 773-74.
    • (2007) J Child Neurol , vol.22 , pp. 773-774
    • Vodopiutz, J.1    Item, C.B.2    Häusler, M.3    Korall, H.4    Bodamer, O.A.5
  • 7
    • 34547110514 scopus 로고    scopus 로고
    • Global developmental delay in guanidinoacetate methyltransferase deficiency: Differences in formal testing and clinical observation
    • Verbruggen KT, Knijff WA, Soorani-Lunsing RJ, et al. Global developmental delay in guanidinoacetate methyltransferase deficiency: differences in formal testing and clinical observation. Eur J Pediatr 2007; 166: 921-25.
    • (2007) Eur J Pediatr , vol.166 , pp. 921-925
    • Verbruggen, K.T.1    Knijff, W.A.2    Soorani-Lunsing, R.J.3
  • 9
    • 0037304972 scopus 로고    scopus 로고
    • A role for guanidino compounds in the brain
    • Hiramatsu M. A role for guanidino compounds in the brain. Mol Cell Biochem 2003; 244: 57-62.
    • (2003) Mol Cell Biochem , vol.244 , pp. 57-62
    • Hiramatsu, M.1
  • 10
    • 0035694594 scopus 로고    scopus 로고
    • Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation
    • Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001; 74: 413-19.
    • (2001) Mol Genet Metab , vol.74 , pp. 413-419
    • Schulze, A.1    Ebinger, F.2    Rating, D.3    Mayatepek, E.4
  • 11
    • 34249297046 scopus 로고    scopus 로고
    • Successful treatment of a guanidinoacetate methyltransferase deficient patient: Findings with relevance to treatment strategy and pathophysiology
    • Verbruggen KT, Sijens PE, Schulze A, Lunsing RJ, Jakobs C, Salomons GS, van Spronsen FJ. Successful treatment of a guanidinoacetate methyltransferase deficient patient: Findings with relevance to treatment strategy and pathophysiology. Mol Genet Metab 2007; 91: 294-96.
    • (2007) Mol Genet Metab , vol.91 , pp. 294-296
    • Verbruggen, K.T.1    Sijens, P.E.2    Schulze, A.3    Lunsing, R.J.4    Jakobs, C.5    Salomons, G.S.6    van Spronsen, F.J.7
  • 12
    • 33747680298 scopus 로고    scopus 로고
    • Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency
    • Schulze A, Hoffmann GF, Bachert P, et al. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 2006; 67: 719-21.
    • (2006) Neurology , vol.67 , pp. 719-721
    • Schulze, A.1    Hoffmann, G.F.2    Bachert, P.3
  • 13
    • 20044386883 scopus 로고    scopus 로고
    • Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation
    • Caldeira Araujo H, Smit W, Verhoeven NM, et al. Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A 2006; 133: 122-27.
    • (2006) Am J Med Genet A , vol.133 , pp. 122-127
    • Caldeira Araujo, H.1    Smit, W.2    Verhoeven, N.M.3
  • 14
    • 3242725272 scopus 로고    scopus 로고
    • Creatine and guanidinoacetate: Diagnostic markers for inborn errors in creatine biosynthesis and transport
    • Almeida LS, Verhoeven NM, Roos B, et al. Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 2004; 82: 214-19.
    • (2004) Mol Genet Metab , vol.82 , pp. 214-219
    • Almeida, L.S.1    Verhoeven, N.M.2    Roos, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.